0001127602-23-018287.txt : 20230608
0001127602-23-018287.hdr.sgml : 20230608
20230608162953
ACCESSION NUMBER: 0001127602-23-018287
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230606
FILED AS OF DATE: 20230608
DATE AS OF CHANGE: 20230608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vickers Philip J.
CENTRAL INDEX KEY: 0001635046
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38537
FILM NUMBER: 231002297
MAIL ADDRESS:
STREET 1: C/O REVANCE THERAPEUTICS, INC.
STREET 2: 7555 GATEWAY BOULEVARD
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVROBIO, Inc.
CENTRAL INDEX KEY: 0001681087
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 810710585
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 TECHNOLOGY SQUARE
STREET 2: 6TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617.914.8420
MAIL ADDRESS:
STREET 1: 100 TECHNOLOGY SQUARE
STREET 2: 6TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AvroBio, Inc.
DATE OF NAME CHANGE: 20160729
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-06-06
0001681087
AVROBIO, Inc.
AVRO
0001635046
Vickers Philip J.
C/O AVROBIO, INC.
100 TECHNOLOGY SQUARE, 6TH FLOOR
CAMBRIDGE
MA
02139
1
0
Stock Option (Right to Buy)
1.09
2023-06-06
4
A
0
17643
0
A
2033-06-05
Common Stock
17643
17643
D
The option shall vest in full upon the earlier of June 6, 2024 or the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date.
/s/ Steven Avruch, Attorney-in-Fact for Philip J. Vickers
2023-06-08